Navigation Links
Nerve Stimulator for Depression Though Not Effective Was Given Approval

A pacemaker-like device which has to be surgically implanted called the vagus nerve stimulator was approved by a top federal medical official against the opinion of his scientific staff . //

This device is used in the treatment of persistent depression. As it was no approved by the staff due to its ineffectiveness in its only clinical trial, it was rejected. Cyberonics Inc is the maker and planned to sell it for the treatment against depression. But Dr. Daniel G. Schultz, director of the Center for Devices and Radiological Health at the agency despite all these facts eventually decided to approve it.

Susan Bro, an F.D.A. spokeswoman, said that the device was approved because many people with persistent depression are on their way to institutionalization, because of the seriousness of their illness. To prevent it they had given approval for the device. She said that staff recommendations were overruled after assessing all data, expert opinion and medical need.

Robert P. Cummins, Cyberonics's chairman and chief executive, said that the investigators had failed to interview many experts on serious depression. He also said that the device was very safe and effective against the treatment of chronic or recurrent treatment-resistant depression.

The vagus nerve stimulator is surgically implanted in the upper chest, and its wires are threaded into the neck. Batteries in the device stimulate a nerve leading to the brain.

It was approved for the treatment of epilepsy in some patients. Common side effects are voice alteration, increased cough, shortness of breath, neck pain and difficulty in swallowing. In rare case reports of death, heart problems and vocal cord paralysis are also mentioned.

Cyberonics implanted the device in 235 patients and found only 30 % showed significant improvement after six months.


'"/>




Page: 1

Related medicine news :

1. Epilepsy Drug Helps Diabetic Nerve Damage
2. World’s First Nerve Stem Cells Produced
3. Children With Epilepsy Can Be Treated With Nerve Stimulation
4. FDA Approved Nerve-Stimulation Therapy Now Available In New York
5. Doctors Finish Mother-To-Son Nerve Surgery
6. Stem Cells From Hair Follicle To Repair Nerve Damage
7. Nerve regeneration for Spinal cord injuries
8. Novel Protein, Staufen2 Important In Maintenance Of Nerve Synapses
9. Dividing Nerve Cells Could Trigger Alzheimers Disease
10. Protein Found to Be Essential For Maintaining Nerve Health
11. Nerve Damage Can Be Prevented By Xenon Administration During Surgery
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/28/2017)... ... June 28, 2017 , ... The parent company ... in employee engagement. Omaha-based C&A Industries, a national leader in staffing and ... in North America for 2017. The annual award, issued by Achievers, ...
(Date:6/28/2017)... Church, VA (PRWEB) , ... June 28, 2017 , ... ... http://www.fdanews.com/fdaeumdregs      , No matter on which side of the Atlantic devicemakers ... medical device regulations they have to follow. , In addition to the full text ...
(Date:6/28/2017)... ... June 28, 2017 , ... Eating disorders have the highest mortality ... at least one person dies as a direct result from an eating disorder in ... qualified treatment providers. The iaedp Foundation meets this challenge by offering what has become ...
(Date:6/28/2017)... ... June 28, 2017 , ... American Farmer proudly announces the participation of ... winning television series, scheduled to broadcast fourth quarter 2017. American Farmer airs Tuesdays at ... supplier of garden pea seed. As demand grew, the small company located in Moscow, ...
(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... ... insurance management and financial planning assistance to clients in southern Montana, is announcing ... offered by Zoo Montana. , The outreach programs offered by Zoo Montana provide ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... , June 7, 2017  Novavax, Inc., (Nasdaq: ... of two Phase 2 trials of its RSV F protein ... child bearing age have been published in the journal ... have been shared in prior scientific conferences). The Company previously ... April 2014. Novavax is developing the RSV F Vaccine with ...
(Date:6/2/2017)... Mass. , June 2, 2017  NxStage Medical, ... renal care, today announced new findings demonstrating positive biochemical ... ® System One™. The data will be presented ... in Madrid, Spain . ... to Improve Home Dialysis Network in Europe ...
(Date:5/29/2017)...  Cellect Biotechnology Ltd. (NASDAQ: APOP ; TASE: ... functional selection of stem cells, today provided a corporate ... ended March 31 st , 2017. ... first quarter of 2017," said Dr. Shai Yarkoni, Chief ... treatment of the first blood cancer patient in the ...
Breaking Medicine Technology: